EBIT at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s EBIT?
- ArriVent BioPharma, Inc. (AVBP) reported EBIT of -$46.11M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s EBIT changed year-over-year?
- ArriVent BioPharma, Inc.'s EBIT increased by 30.9% year-over-year, from -$66.77M to -$46.11M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s EBIT?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s EBIT has grown at a 54.3% compound annual growth rate (CAGR), from -$74.59M to -$177.53M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.